China National Accord Medicines Corp Ltd (SHE:200028) — Stock Price

HK$11.94 HKD
▲ 0.67% today

China National Accord Medicines Corp Ltd (SHE:200028) is currently trading at HK$11.94 HKD, up 0.67% today. Over the past 52 weeks, shares have ranged between HK$11.60 and HK$14.07. This page tracks China National Accord Medicines Corp Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 200028 market cap.

China National Accord Medicines Corp Ltd (200028) Stock Price Chart — Daily History & Trading Volume

The chart below tracks China National Accord Medicines Corp Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.

China National Accord Medicines Corp Ltd Income Statement — Revenue, Profit & Earnings by Year

China National Accord Medicines Corp Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue HK$71.52 Billion HK$74.38 Billion HK$75.48 Billion HK$73.44 Billion HK$68.36 Billion
Cost of Revenue HK$65.58 Billion HK$66.18 Billion HK$66.47 Billion HK$64.56 Billion HK$60.37 Billion
Gross Profit HK$7.84 Billion HK$8.20 Billion HK$9.01 Billion HK$8.88 Billion HK$7.99 Billion
Research & Development HK$19.99 Million HK$24.55 Million HK$26.82 Million HK$9.07 Million HK$7.74 Million
SG&A HK$1.43 Billion HK$1.05 Billion HK$1.08 Billion HK$1.10 Billion HK$1.01 Billion
Total Operating Expenses HK$70.04 Billion HK$7.62 Billion HK$6.54 Billion HK$6.58 Billion HK$6.03 Billion
Operating Income HK$1.47 Billion HK$573.48 Million HK$2.47 Billion HK$2.31 Billion HK$1.95 Billion
EBITDA HK$1.47 Billion HK$1.06 Billion HK$4.15 Billion HK$2.82 Billion HK$2.47 Billion
EBIT — HK$833.77 Million HK$2.72 Billion HK$2.57 Billion HK$2.26 Billion
Interest Expense HK$194.50 Million HK$258.30 Million HK$248.38 Million HK$261.91 Million HK$288.04 Million
Income Before Tax HK$1.47 Billion HK$575.47 Million HK$2.47 Billion HK$2.31 Billion HK$1.97 Billion
Income Tax Expense — HK$338.47 Million HK$514.74 Million HK$539.33 Million HK$447.21 Million
Net Income HK$1.11 Billion HK$642.49 Million HK$1.60 Billion HK$1.49 Billion HK$1.34 Billion

China National Accord Medicines Corp Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes China National Accord Medicines Corp Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets HK$49.10 Billion HK$47.56 Billion HK$47.57 Billion HK$42.62 Billion HK$42.78 Billion
Total Current Assets HK$40.20 Billion HK$37.58 Billion HK$36.37 Billion HK$31.71 Billion HK$31.85 Billion
Cash & Equivalents — — — — —
Short-term Investments — — HK$-639.06 Million HK$2.00 HK$-747.96 Million
Net Receivables HK$21.54 Billion HK$21.85 Billion HK$20.24 Billion HK$16.20 Billion HK$17.70 Billion
Inventory HK$8.12 Billion HK$7.41 Billion HK$7.99 Billion HK$7.84 Billion HK$7.62 Billion
Property, Plant & Equipment — — — HK$3.41 Billion HK$3.49 Billion
Goodwill HK$1.60 Billion HK$1.86 Billion HK$2.75 Billion HK$2.75 Billion HK$2.78 Billion
Total Liabilities HK$27.47 Billion HK$26.80 Billion HK$26.59 Billion HK$23.17 Billion HK$24.76 Billion
Total Current Liabilities HK$26.11 Billion HK$24.80 Billion HK$24.34 Billion HK$21.03 Billion HK$22.38 Billion
Long-term Debt — — — HK$17.50 Million HK$71.64 Million
Net Debt — HK$-3.02 Billion HK$-1.42 Billion HK$-2.50 Billion HK$-900.30 Million
Total Stockholder Equity HK$18.61 Billion HK$17.67 Billion HK$17.41 Billion HK$16.13 Billion HK$14.92 Billion
Retained Earnings HK$13.51 Billion HK$12.58 Billion HK$12.59 Billion HK$11.12 Billion HK$9.89 Billion

China National Accord Medicines Corp Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how China National Accord Medicines Corp Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow HK$1.64 Billion HK$3.27 Billion HK$2.94 Billion HK$2.56 Billion HK$1.66 Billion
Capital Expenditures HK$217.35 Million HK$282.70 Million HK$322.21 Million HK$322.19 Million HK$370.43 Million
Free Cash Flow HK$1.42 Billion HK$2.99 Billion HK$2.61 Billion HK$2.24 Billion HK$1.28 Billion
Investing Cash Flow — HK$-150.69 Million HK$-135.43 Million HK$-342.82 Million HK$-455.53 Million
Financing Cash Flow — HK$-1.83 Billion HK$-2.41 Billion HK$-1.51 Billion HK$-1.87 Billion
Dividends Paid HK$-386.29 Million HK$603.77 Million HK$559.07 Million HK$574.19 Million HK$610.54 Million
Stock-Based Compensation — — — — —
Depreciation HK$1.26 Billion HK$1.55 Billion HK$1.43 Billion HK$1.31 Billion HK$1.27 Billion
Change in Cash HK$173.36 Million HK$1.29 Billion HK$393.12 Million HK$708.66 Million HK$-671.60 Million

China National Accord Medicines Corp Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track China National Accord Medicines Corp Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 30, 2026 0.58 — —
Oct 31, 2025 0.57 — —
Aug 30, 2025 0.66 — —
Apr 24, 2025 0.63 — —
Mar 18, 2025 -0.82 — —
Oct 28, 2024 0.63 — —
Aug 28, 2024 0.69 — —
Apr 25, 2024 0.80 — —